Company: CORT
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001628280-25-022173
Chunk: 198

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 4
Chunk 198
---
 as part of the cashless net exercises of stock options and vesting of restricted stock (in thousands, except average price per share):

Fiscal PeriodTotal Number of Shares Purchased(1)Average Price Per ShareTotal Purchase Price of Shares(2)January 1, 2025 to January 31, 2025134 $57.64 $7,710 February 1, 2025 to February 28, 2025129 67.79 8,707 March 1, 2025 to March 31, 202579 58.80 4,669 Total342 $61.72 $21,086 

(1)In January 2025, we issued 235,978 shares of common stock as part of net-share settlement of cashless option exercises, of which 124,840 shares were surrendered to us in satisfaction of related exercise cost and tax obligations. In February 2025, we issued 190,708 shares of common stock as part of net-share settlement of cashless option exercises, of which 107,705 shares were surrendered to us. In March 2025, we issued 165,406 shares of common stock as part of net-share settlement of cashless option exercises, of which 62,818 shares were surrendered to us. In January 2025, we issued 22,588 shares of common stock as part of restricted award vesting, of which 8,934 shares were surrendered to us in satisfaction of related tax obligations. In February 2025, we issued 51,499 shares of common stock as part of restricted award vesting, of which 20,731 shares were surrendered to us. In March 2025, we issued 44,095 shares of common stock as part of restricted award vesting, of which 16,595 shares were surrendered to us.(2)We paid $15.8 million to satisfy the tax withholding obligations associated with the net-share settlement of these cashless option exercises and restricted stock vesting.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

Not applicable.